Results 11 to 20 of about 48,908 (228)

Rifampin-resistant Meningococcal Disease

open access: yesEmerging Infectious Diseases, 2005
Rifampin-resistant meningococcal disease occurred in a child who had completed rifampin chemoprophylaxis for exposure to a sibling with meningococcemia. Susceptibility testing of 331 case isolates found only 1 other case of rifampin-resistant disease in ...
Jean Rainbow   +5 more
doaj   +2 more sources

Controversy about the Role of Rifampin in Biofilm Infections: Is It Justified? [PDF]

open access: yesAntibiotics, 2021
Rifampin is a potent antibiotic against staphylococcal implant-associated infections. In the absence of implants, current data suggest against the use of rifampin combinations.
Nora Renz   +2 more
doaj   +2 more sources

Assessing transporter-mediated rifampin-linezolid interaction using physiologically-based pharmacokinetic modelling. [PDF]

open access: yesBr J Clin Pharmacol
Abstract Aims The study aims to develop a physiologically‐based pharmacokinetic (PBPK) model to quantitatively evaluate the role of ATP‐binding cassette sub‐family B member 1 (ABCB1) and ATP‐binding cassette super‐family G member 2 (ABCG2) in the drug–drug interaction (DDI) between rifampin and linezolid and to predict the impact of high‐dose rifampin ...
Nguyen HD   +4 more
europepmc   +2 more sources

Rifampin-Associated Renal Failure

open access: yesAnnals of Internal Medicine: Clinical Cases, 2023
Rifampin is an effective and widely used for the treatment of both active and latent tuberculosis. Although significant side effects are rare, severe side effects such as acute renal failure have been reported in the literature, usually secondary to ...
Kathleen Miller   +2 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

CAQ Corner: Basic concepts of transplant immunology

open access: yes, 2022
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley   +1 more source

COVID-19 as a Potential Trigger for Tuberculosis: Insights From a Large-Scale Japanese Insurance Database Analysis. [PDF]

open access: yesJ Gen Fam Med
In a nationwide propensity score–matched cohort study using Japanese insurance claims data, prior COVID‐19 was associated with a fourfold higher risk of subsequent active tuberculosis treatment initiation. The association was particularly pronounced among individuals with prior tuberculosis history.
Miyamori D, Ikeda K, Nagasaka S, Ito M.
europepmc   +2 more sources

Innovative methods for the diagnosis and treatment of implant-associated infections [PDF]

open access: yes, 2009
Indwelling devices and prosthesis are increasingly used in modern medicine practices. Failures of prosthetic joint devices constitute an important complication. Especially, the management of patients with a septic failure is characterized by difficulties
Baldoni, Daniela
core   +1 more source

Rifampin Regulation of Drug Transporters Gene Expression and the Association of MicroRNAs in Human Hepatocytes

open access: yesFrontiers in Pharmacology, 2016
Membrane drug transporters contribute to the disposition of many drugs. In human liver, drug transport is controlled by two main superfamilies of transporters, the solute carrier transporters (SLC) and the ATP Binding Cassette transporters (ABC). Altered
Eric A Benson   +8 more
doaj   +1 more source

Effect of the nanoliposomal formulations of rifampin and N-acetyl cysteine on staphylococcus epidermidis biofilm [PDF]

open access: yesNanomedicine Journal, 2020
Objective(s): Staphylococcus epidermidis is a common cause of medical device-associated infections due to biofilm formation, and its elimination is extremely challenging. Although rifampin efficacy against S.
Farzaneh Bazrgari   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy